Loading resource…

Prateek C. Gandiga, Daniela Ghetie, Elizabeth Anderson, Rohit Aggrawal
Idiopathic inflammatory myopathies (IIM) are a complex family of autoimmune systemic disorders that significantly impact muscle and skin. The optimal treatment for IIM remains uncertain, which is why this guide focuses on the use of IVIG and SCIG based on recent literature and clinical experience. It discusses the safety, formulations, and costs associated with IVIG, along with its effectiveness in treating muscular and extra-muscular manifestations of IIM. The guide also addresses special circumstances such as myositis-related dysphagia and interstitial lung disease.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial
Same clinical topic · Rheumatology

EARLY TRAUMA AS THE ORIGIN OF CHRONIC INFLAMMATION: A PSYCHONEUROIMMUNOLOGICAL PERSPECTIVE
Same clinical topic · Rheumatology

IDIOPATHIC INFLAMMATORY MYOPATHIES
Same clinical topic · Rheumatology

MULTIFACTORIAL PATHOGENESIS OF RHEUMATOID ARTHRITIS
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS IN CRITICAL CARE: A SYSTEMATIC REVIEW OF ICU OUTCOMES AND MANAGEMENT
Same clinical topic · Rheumatology

RHEUMATOID ARTHRITIS — COMMON ORIGINS, DIVERGENT MECHANISMS
Same clinical topic · Rheumatology

RHEUMATOID ARTHRITIS IN ADULTS
Same clinical topic · Rheumatology

BIOLOGICAL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS AND TREATMENT
Same clinical topic · Rheumatology